Healthcare provider profile · identity verified

Michael Joseph Dominguez, MD

Family Practice · SAN ANTONIO, TX · NPI 1689674509

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	584	183
Amlodipine Besylate	Amlodipine Besylate	283	92
Metformin Hcl	Metformin Hcl	239	81
Lisinopril	Lisinopril	229	78
Metoprolol Succinate	Metoprolol Succinate	176	61
Tamsulosin Hcl	Tamsulosin Hcl	170	60
Rosuvastatin Calcium	Rosuvastatin Calcium	160	62
Levothyroxine Sodium	Levothyroxine Sodium	157	52
Tramadol Hcl	Tramadol Hcl	150	55
Pantoprazole Sodium	Pantoprazole Sodium	146	54
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	133	48
Losartan Potassium	Losartan Potassium	132	45
Gabapentin	Gabapentin	120	50
Farxiga	Dapagliflozin Propanediol	115	30
Carvedilol	Carvedilol	103	36
Ramipril	Ramipril	102	32
Jardiance	Empagliflozin	96	27
Enalapril Maleate	Enalapril Maleate	92	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	89	29
Ozempic	Semaglutide	89	21
Hydrochlorothiazide	Hydrochlorothiazide	83	29
Metformin Hcl Er	Metformin Hcl	80	27
Omeprazole	Omeprazole	72	27
Montelukast Sodium	Montelukast Sodium	69	20
Eliquis	Apixaban	68	15
Famotidine	Famotidine	67	24
Fluticasone Propionate	Fluticasone Propionate	62	28
Pregabalin	Pregabalin	62	19
Finasteride	Finasteride	59	18
Metoprolol Tartrate	Metoprolol Tartrate	59	21
Myrbetriq	Mirabegron	59	19
Albuterol Sulfate Hfa	Albuterol Sulfate	58	30
Clopidogrel	Clopidogrel Bisulfate	57	21
Duloxetine Hcl	Duloxetine Hcl	56	21
Acetaminophen-Codeine	Acetaminophen With Codeine	54	26
Clonazepam	Clonazepam	51	12
Simvastatin	Simvastatin	51	17
Trazodone Hcl	Trazodone Hcl	48	22
Furosemide	Furosemide	46	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	39
Irbesartan	Irbesartan	45	18
Meloxicam	Meloxicam	45	19
Alendronate Sodium	Alendronate Sodium	43	14
Pravastatin Sodium	Pravastatin Sodium	43	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	14
Hydroxyzine Hcl	Hydroxyzine Hcl	37	12
Latanoprost	Latanoprost	37	suppressed
Nifedipine Er	Nifedipine	37	11
Ezetimibe	Ezetimibe	36	14
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	35	13
Benazepril Hcl	Benazepril Hcl	34	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	34	13
Ibuprofen	Ibuprofen	34	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	11
Tizanidine Hcl	Tizanidine Hcl	34	17
Diclofenac Sodium	Diclofenac Sodium	33	14
Januvia	Sitagliptin Phosphate	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	11
Vitamin D2	Ergocalciferol (Vitamin D2)	31	12
Spironolactone	Spironolactone	30	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	30	13
Citalopram Hbr	Citalopram Hydrobromide	29	11
Paroxetine Hcl	Paroxetine Hcl	28	11
Allopurinol	Allopurinol	26	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Incontrol Pen Needle	Pen Needle, Diabetic	26	17
Levetiracetam	Levetiracetam	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Sertraline Hcl	Sertraline Hcl	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Nitroglycerin	Nitroglycerin	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	suppressed
Valsartan	Valsartan	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Glipizide	Glipizide	22	11
Linzess	Linaclotide	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Potassium Chloride	Potassium Chloride	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Humalog Kwikpen U-200	Insulin Lispro	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	16	12
Memantine Hcl	Memantine Hcl	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Clonidine Hcl	Clonidine Hcl	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Prednisone	Prednisone	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	12
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Risperidone Odt	Risperidone	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error